JP2016526688A - ルテリアルの形態学的特性を用いた疾病の診断方法 - Google Patents

ルテリアルの形態学的特性を用いた疾病の診断方法 Download PDF

Info

Publication number
JP2016526688A
JP2016526688A JP2016525261A JP2016525261A JP2016526688A JP 2016526688 A JP2016526688 A JP 2016526688A JP 2016525261 A JP2016525261 A JP 2016525261A JP 2016525261 A JP2016525261 A JP 2016525261A JP 2016526688 A JP2016526688 A JP 2016526688A
Authority
JP
Japan
Prior art keywords
cancer
ruterial
disease
prognosis
suspected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016525261A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016526688A5 (https=
Inventor
ヨンア クォン
ヨンア クォン
ウォンチョル チョイ
ウォンチョル チョイ
ソクフン チョイ
ソクフン チョイ
チャンフン チョイ
チャンフン チョイ
ソンピル クォン
ソンピル クォン
ヒョンジョン チョン
ヒョンジョン チョン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2016526688A publication Critical patent/JP2016526688A/ja
Publication of JP2016526688A5 publication Critical patent/JP2016526688A5/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/4833—Physical analysis of biological material of solid biological material, e.g. tissue samples, cell cultures
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7023—(Hyper)proliferation
    • G01N2800/7028—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nanotechnology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Ecology (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
JP2016525261A 2013-07-12 2014-01-14 ルテリアルの形態学的特性を用いた疾病の診断方法 Pending JP2016526688A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2013-0082060 2013-07-12
KR20130082060 2013-07-12
PCT/KR2014/000393 WO2015005553A1 (ko) 2013-07-12 2014-01-14 루테리알의 형태특성을 이용한 질병의 진단방법

Publications (2)

Publication Number Publication Date
JP2016526688A true JP2016526688A (ja) 2016-09-05
JP2016526688A5 JP2016526688A5 (https=) 2017-09-07

Family

ID=52280202

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016525261A Pending JP2016526688A (ja) 2013-07-12 2014-01-14 ルテリアルの形態学的特性を用いた疾病の診断方法

Country Status (6)

Country Link
US (1) US10338061B2 (https=)
EP (1) EP3021119A4 (https=)
JP (1) JP2016526688A (https=)
KR (8) KR20150007922A (https=)
CN (1) CN106068455B (https=)
WO (1) WO2015005553A1 (https=)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017505448A (ja) * 2014-01-14 2017-02-16 チョイ ウォンチョルＣＨＯＩ， Ｗｏｎ Ｃｈｅｏｌ ルテリアルの形態特性を用いた癌予防剤または抗癌剤のスクリーニング方法
JP2017510248A (ja) * 2014-01-14 2017-04-13 チョイ ウォンチョルＣＨＯＩ， Ｗｏｎ Ｃｈｅｏｌ ルテリアル、並びにその分離および培養方法
JP2018502581A (ja) * 2015-01-06 2018-02-01 ルテリオン カンパニー リミテッドＬｕｔｅｒｉｏｎ Ｃｏ．， Ｌｔｄ． ルテリオンおよびその分離・培養方法
US10590384B2 (en) 2014-01-14 2020-03-17 Luterion Co., Ltd. Luterial and method for isolating and culturing the same

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014299561B2 (en) 2013-06-24 2017-06-08 Ablbio Antibody-drug conjugate having improved stability and use thereof
KR101766373B1 (ko) * 2015-01-05 2017-08-09 권영아 루테리온을 이용한 암세포의 텔로머라아제 억제방법
US20230090858A1 (en) * 2021-09-23 2023-03-23 The Trustees Of The University Of Pennsylvania Analysis of pleural lines for the diagnosis of lung conditions
US12196755B2 (en) 2021-12-02 2025-01-14 Zymeron Corporation Immunoassay platform for the serological discrimination of closely related viruses

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5020822A (https=) * 1973-05-24 1975-03-05
JPS56140253A (en) * 1980-03-12 1981-11-02 Kasu Roorensu Identification of type of white corpuscle by different color dye
JPH0412243A (ja) * 1990-05-02 1992-01-16 Asahi Chem Ind Co Ltd 直孔性フィルター及びその製造方法
WO2000022432A1 (en) * 1998-10-08 2000-04-20 Silvia Maria Doglia A method for the detection of mitochondrial alterations
JP2002223768A (ja) * 2001-01-31 2002-08-13 Japan Science & Technology Corp ヒトミトコンドリア蛋白質とこの蛋白質をコードするポリヌクレオチド
JP2005525124A (ja) * 2002-05-14 2005-08-25 ザ チャイニーズ ユニバーシティ オブ ホンコン 核酸の検出及び分画により病態を評価する方法
WO2006054296A2 (en) * 2004-11-17 2006-05-26 Spectrum Dynamics Llc Methods of detecting prostate cancer
JP2008500514A (ja) * 2004-02-13 2008-01-10 ジェームズ ウィンケルマン 倒立顕微鏡を用いた血液構成要素の識別
JP2011510663A (ja) * 2008-02-01 2011-04-07 ザ ジェネラル ホスピタル コーポレイション 医学的疾患および医学的状態の診断、予後および治療におけるマイクロベシクルの使用
JP2011163830A (ja) * 2010-02-05 2011-08-25 Tokyo Univ Of Agriculture & Technology サイズ選択マイクロキャビティアレイを用いた循環腫瘍細胞の検出
JP2012111735A (ja) * 2010-11-26 2012-06-14 Uha Mikakuto Co Ltd 新規レスベラトロール誘導体
WO2012135844A2 (en) * 2011-04-01 2012-10-04 Cornell University Circulating exosomes as diagnostic/prognostic indicators and therapeutic targets of melanoma and other cancers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6064909A (ja) 1983-09-20 1985-04-13 Shiseido Co Ltd 化粧料
KR20030033134A (ko) * 2001-10-17 2003-05-01 장준근 적혈구의 물리적 특성을 이용한 질환 진단 장치 및 그진단 방법
CA2634591A1 (en) * 2005-12-22 2007-07-05 Memorial Sloan-Kettering Cancer Center Method for detection of cancer cells using virus
HK1231516A1 (zh) 2014-01-14 2017-12-22 崔元哲 Luterial和用於其分离及培养的方法
HK1231558A1 (zh) 2014-01-14 2017-12-22 崔元哲 使用luterial的形态学特徵筛选癌症预防剂或抗癌剂的方法

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5020822A (https=) * 1973-05-24 1975-03-05
JPS56140253A (en) * 1980-03-12 1981-11-02 Kasu Roorensu Identification of type of white corpuscle by different color dye
JPH0412243A (ja) * 1990-05-02 1992-01-16 Asahi Chem Ind Co Ltd 直孔性フィルター及びその製造方法
WO2000022432A1 (en) * 1998-10-08 2000-04-20 Silvia Maria Doglia A method for the detection of mitochondrial alterations
JP2002223768A (ja) * 2001-01-31 2002-08-13 Japan Science & Technology Corp ヒトミトコンドリア蛋白質とこの蛋白質をコードするポリヌクレオチド
JP2005525124A (ja) * 2002-05-14 2005-08-25 ザ チャイニーズ ユニバーシティ オブ ホンコン 核酸の検出及び分画により病態を評価する方法
JP2008500514A (ja) * 2004-02-13 2008-01-10 ジェームズ ウィンケルマン 倒立顕微鏡を用いた血液構成要素の識別
WO2006054296A2 (en) * 2004-11-17 2006-05-26 Spectrum Dynamics Llc Methods of detecting prostate cancer
JP2011510663A (ja) * 2008-02-01 2011-04-07 ザ ジェネラル ホスピタル コーポレイション 医学的疾患および医学的状態の診断、予後および治療におけるマイクロベシクルの使用
JP2011163830A (ja) * 2010-02-05 2011-08-25 Tokyo Univ Of Agriculture & Technology サイズ選択マイクロキャビティアレイを用いた循環腫瘍細胞の検出
JP2012111735A (ja) * 2010-11-26 2012-06-14 Uha Mikakuto Co Ltd 新規レスベラトロール誘導体
WO2012135844A2 (en) * 2011-04-01 2012-10-04 Cornell University Circulating exosomes as diagnostic/prognostic indicators and therapeutic targets of melanoma and other cancers

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017505448A (ja) * 2014-01-14 2017-02-16 チョイ ウォンチョルＣＨＯＩ， Ｗｏｎ Ｃｈｅｏｌ ルテリアルの形態特性を用いた癌予防剤または抗癌剤のスクリーニング方法
JP2017510248A (ja) * 2014-01-14 2017-04-13 チョイ ウォンチョルＣＨＯＩ， Ｗｏｎ Ｃｈｅｏｌ ルテリアル、並びにその分離および培養方法
JP2018201519A (ja) * 2014-01-14 2018-12-27 チョイ ウォンチョルＣＨＯＩ， Ｗｏｎ Ｃｈｅｏｌ ルテリアル、並びにその分離および培養方法
JP2019023643A (ja) * 2014-01-14 2019-02-14 チョイ ウォンチョルＣＨＯＩ， Ｗｏｎ Ｃｈｅｏｌ ルテリアルの形態特性を用いた癌予防剤または抗癌剤のスクリーニング方法
US10590384B2 (en) 2014-01-14 2020-03-17 Luterion Co., Ltd. Luterial and method for isolating and culturing the same
US10624926B2 (en) 2014-01-14 2020-04-21 Luterion Co., Ltd. Luterial and method for isolating and culturing the same
JP2018502581A (ja) * 2015-01-06 2018-02-01 ルテリオン カンパニー リミテッドＬｕｔｅｒｉｏｎ Ｃｏ．， Ｌｔｄ． ルテリオンおよびその分離・培養方法
JP2019205467A (ja) * 2015-01-06 2019-12-05 ルテリオン カンパニー リミテッドＬｕｔｅｒｉｏｎ Ｃｏ．， Ｌｔｄ． ルテリオンおよびその分離・培養方法
US10569194B2 (en) 2015-01-06 2020-02-25 Luterion Co., Ltd. Luterion and separating and culturing methods for same
JP2021180679A (ja) * 2015-01-06 2021-11-25 ルテリオン カンパニー リミテッドLuterion Co., Ltd. ルテリオンおよびその分離・培養方法
JP2023145725A (ja) * 2015-01-06 2023-10-11 ルテリオン カンパニー リミテッド ルテリオンおよびその分離・培養方法
JP2025060936A (ja) * 2015-01-06 2025-04-10 ルテリオン カンパニー リミテッド ルテリオンおよびその分離・培養方法

Also Published As

Publication number Publication date
US20160169870A1 (en) 2016-06-16
WO2015005553A1 (ko) 2015-01-15
CN106068455A (zh) 2016-11-02
KR20230009999A (ko) 2023-01-17
EP3021119A4 (en) 2017-04-19
US10338061B2 (en) 2019-07-02
KR20200139117A (ko) 2020-12-11
KR20250102000A (ko) 2025-07-04
KR20160115886A (ko) 2016-10-06
CN106068455B (zh) 2018-05-11
KR20220050844A (ko) 2022-04-25
KR20240001089A (ko) 2024-01-03
KR20150007922A (ko) 2015-01-21
KR20200007065A (ko) 2020-01-21
EP3021119A1 (en) 2016-05-18

Similar Documents

Publication Publication Date Title
JP2016526688A (ja) ルテリアルの形態学的特性を用いた疾病の診断方法
Maier et al. The clinical value of urinary cytology: 12 years of experience with 615 patients.
JP2023055865A (ja) ルテリアル、並びにその分離および培養方法
EP3768172B1 (en) Method to induce exfoliation of cells and/or tissue fragments for enhanced cytopathologic cell collection
CN101606060A (zh) 细胞图像的归类方法
JP2017129584A (ja) 希少細胞を用いて癌患者の予後を予測する方法
CN118050512A (zh) 检测来自尿液囊泡的蛋白标志物的试剂在制备乳腺癌诊断试剂盒中的应用
Iordache et al. NBI-assisted digital flexible ureteroscopy in transitional renal cell carcinoma-an evidence-based assessment" through the looking glass" of the pathological analysis
CN109100504A (zh) 一种血小板-白细胞混合膜包被免疫磁珠及其制备方法与应用
Tomizawa et al. Unusual presentation of localized gastric mucosa-associated lymphoid tissue lymphoma mimicking poorly differentiated gastric adenocarcinoma
RU2469324C1 (ru) Способ оценки состояния слизистой оболочки желудка у детей
CN114134116B (zh) 预测结直肠癌患者化疗药物疗效的试剂盒及其应用
RU2371719C2 (ru) Способ диагностики лямблиозной инвазии
CN113238052A (zh) MG7-Ag、hTERT及TFF2表达分析在肠上皮化生风险分层及胃癌预警中的应用
US10590384B2 (en) Luterial and method for isolating and culturing the same
CN117990910B (zh) Ifit1在低黏附型胃癌患者的预后评估中的应用
JPWO2019039415A1 (ja) 腎臓がんの検出方法
JP6147878B2 (ja) 画像診断用量子ドット
Miao et al. Spatiotemporal identification of therapeutic markers via dual-targeted SERS bioprobes for assessing breast cancer progression
CN112904016A (zh) 一种基于蛋白质组学的乳腺癌早期预警方法
Hassan et al. HAEMATURIA;: PHASE CONTRAST MICROSCOPIC EXAMINATION OF 100 CASES FOR LOCALIZATION OF SOURCE OF BLEEDING
Harris et al. The application of Raman spectroscopy to human cancer diagnostics
JP2015121469A (ja) 難治性乳がんの検査方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160311

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160311

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20161212

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170118

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170228

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170525

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20170725

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180109

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20180215

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20180404

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180608

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20181204